Dr. Paul J. Mosca
Overview
My primary area of clinical interest is surgical oncology. My primary focus includes the care of patients with melanoma or other potentially aggressive skin or soft tissue tumors, as well as those in need of lymph node surgery. In addition to patient care and research, I am committed to education and training. It is important to me to be accessible, engaged, and thoughtful in my approach to interacting with patients, colleagues, learners, and other stakeholders. For me, a principle guiding force is a deep-seated belief in patient-centered, multidisciplinary, compassionate, state-of-the-art care that aims to serve our community and support the mission and values of Duke Health.
Dr. Mosca is rated as an Experienced provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lymphofollicular Hyperplasia, Pancreaticoduodenectomy, and Lymphadenectomy.
His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
120 E Carver St, Durham, NC 27704
Additional Areas of Focus
Dr. Mosca has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center Sarcoma Clinic
As an orthopaedic oncologist, I am passionate about providing the best diagnostic and therapeutic surgical care for patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. As the director of the Sarcoma program at the Duke Cancer Institute, my passion is building our team to provide the best clinical care and basic scientific, translational and clinical research to serve our patients. Dr. Brigman is rated as an Elite provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Bone Graft, and Hip Replacement.
Duke Cancer Center
I’m a fellowship-trained surgical oncologist who specializes in the surgical management of patients with gastrointestinal malignancies—including soft tissue sarcomas and pancreas, colorectal and gastric cancers. Many of my patients have advanced malignancies and I am always amazed at their resilience. Their determination to fight inspires me to aggressively pursue every surgical option and to study novel techniques to improve surgical outcomes. One of the most important reasons for patients to be treated at Duke is the emphasis on a team-oriented approach to every patient. Nearly every surgical cancer patient is discussed in a multidisciplinary tumor conference in order to assure state of the art care. When I am not in the hospital, my wife and I can be found chasing our two young children or running with our dog. Dr. Blazer-Iii is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Retroperitoneal Liposarcoma, Desmoplastic Small Round Cell Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.
University Of North Carolina At Chapel Hill
Hong Kim is a Surgical Oncologist and a General Surgeon in Chapel Hill, North Carolina. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Kim is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MelanomaDr. Mosca isDistinguished. Learn about Melanoma.
- Advanced
- Merkel Cell CarcinomaDr. Mosca isAdvanced. Learn about Merkel Cell Carcinoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Mosca isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Mosca isExperienced. Learn about Bone Tumor.
- CholecystitisDr. Mosca isExperienced. Learn about Cholecystitis.
- Epithelioid SarcomaDr. Mosca isExperienced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Mosca isExperienced. Learn about Fibrosarcoma.
- Heart TransplantDr. Mosca isExperienced. Learn about Heart Transplant.